News & Perspective

Nov 06, 2017

Nov 06, 2017

News Scan for Nov 06, 2017

Strep burden, resistance threat
Salmonella probe ends
Ebola susceptibility
MDR-TB in Minnesota

Jun 20, 2017

Jun 20, 2017
Aedes aegypti mosquito

Data on Zika in mosquitoes suggest early presence in Rio

A separate study found Zika virus in the saliva of 5 different mosquito species in Mexico.

Aug 19, 2015

Aug 19, 2015

News Scan for Aug 19, 2015

More Cyclospora cases
Plague in California
Ricin vaccine funding

Oct 29, 2013

Oct 29, 2013

News Scan for Oct 29, 2013

Drop in TB spending
H3N2 dominates global flu
More cholera in Mexico

May 21, 2013

May 21, 2013

Medical conferences spotlight H7N9 threat

(CIDRAP News) – Science and preparedness discussions in the wake of China's H7N9 avian flu outbreak took the stage at two medical meetings today, with experts uneasy about how the virus has behaved so far and questioning its source and if the threat to humans can be contained.

Feb 05, 2013

Feb 05, 2013

NIH launches trio of trials seeking better flu treatments

(CIDRAP News) – Three large, multi-center studies now in the enrollment stage will assess whether such approaches as a combination of antiviral drugs or the use of borrowed antibodies can improve on existing treatments for influenza, the National Institutes of Health (NIH) announced today.

Jul 12, 2010

Jul 12, 2010

ICEID COVERAGE Experts air H1N1 lessons, other disease challenges

– ATLANTA (CIDRAP News) – The vital role of preparedness, from diagnostic testing to stockpiling of antiviral medications, was one of the most important lessons from assessments of the world's response to the H1N1 influenza pandemic, the World Health Organization's (WHO's) top flu expert told an international infectious diseases conference yesterday.

Dec 11, 2009

Dec 11, 2009

New vaccine technologies on horizon but face roadblocks

(CIDRAP News) – New ways of producing influenza vaccine that would free the process from long-standing problems are on the horizon, federal officials said today, but they added that scientific and regulatory hurdles will slow the products' movement past licensure and into the market.

Pages

Sort Results

 

Narrow results

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3M Gilead 
Grant support for ASP provided by

  Become an underwriter»